Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug 1;158(8):2407-2419.
doi: 10.1210/en.2017-00371.

High-Fat Diet and Female Fertility

Affiliations
Review

High-Fat Diet and Female Fertility

Natalie M Hohos et al. Endocrinology. .

Abstract

The prevalence of obesity is high among reproductive-age women and is associated with impaired reproductive function. Obesity is multifactorial in origin, yet many cases of obesity result from overconsumption of a diet high in fat. Excess dietary fat increases both adipose and nonadipose tissue lipid content and, through lipotoxicity, leads to cell dysfunction and death. High dietary fat intake, with or without the development of obesity, impairs female hypothalamic-pituitary-ovarian (HPO) axis functionality and fertility. Based on the current evidence, it appears the reproductive dysfunction involves increased leptin and insulin signaling at the various levels of the HPO axis, as well as changes in peroxisome proliferator-activated receptor γ actions and increased inflammation, yet other mechanisms may also be involved. This review summarizes the current body of knowledge on impaired female reproductive function after high-fat diet exposure, as well as discusses proposed mechanisms through which this may occur.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Proposed mechanisms for HFD-induced central reproductive dysfunction. HFD feeding leads to the development of increased leptin and insulin levels systemically. Elevated leptin levels lead to leptin resistance in the hypothalamus, causing decreased leptin signaling and its ability to inhibit NPY, as seen by an increase in NPY, which inhibits GnRH and likely affects pituitary function as addition of gonadotropin stimulus in this model restored fertility. Inhibiting PPARγ’s actions in the brain protects against leptin resistance and reproductive dysfunction. Elevated insulin levels in the hypothalamus increase GnRH pulse amplitude and lead to increased LH secretion from the pituitary. Alterations in hypothalamic function from both increased leptin and insulin signaling contribute to reproductive dysfunction. Increased insulin and likely increased leptin in the pituitary increase PI3K activation, which alters LH levels and contributes to reproductive dysfunction. LEPR-B, leptin receptor type B.
Figure 2.
Figure 2.
HFD-induced ovarian dysfunction. In the ovary, elevated leptin signaling increases CART, which decreases intracellular cAMP levels and MAPK3/1 activation, leading to decreased aromatase and estradiol production. Elevated levels of leptin, insulin, and KITLG increase PI3K activation, which leads to increased primordial follicle activation, resulting in the depletion of the ovarian reserve. Increased lipid accumulation in the ovary leads to lipotoxicity. Both increased PI3K signaling and lipotoxicity may contribute to increased follicle atresia. These alterations in ovarian function contribute to the reproductive dysfunction. cAMP, cyclic adenosine monophosphate; CART, cocaine- and amphetamine-regulated transcript; MAPK3/1, mitogen-activated protein kinase 3/1.

Similar articles

Cited by

References

    1. Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief. 2015;(219):1–8. - PubMed
    1. Bellver J, Ayllón Y, Ferrando M, Melo M, Goyri E, Pellicer A, Remohí J, Meseguer M. Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil Steril. 2010;93(2):447–454. - PubMed
    1. Rittenberg V, Seshadri S, Sunkara SK, Sobaleva S, Oteng-Ntim E, El-Toukhy T. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online. 2011;23(4):421–439. - PubMed
    1. Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology—a systematic review. Hum Reprod Update. 2007;13(5):433–444. - PubMed
    1. Turner-McGrievy GM, Grant BL. Prevalence of body mass index and body weight cut-off points for in vitro fertilization treatment at U.S. clinics and current clinic weight loss strategy recommendations. Hum Fertil (Camb). 2015;18(3):215–219. - PubMed

Publication types